pH-0064ependent gradient release microspheres of lercanidipine hydrochloride: in vitro and in vivo evaluation

Ungell, 1997, In vitro absorption studies and their relevance to absorption from the GI tract, Drug Dev. Ind. Pharm., 23, 879, 10.3109/03639049709148694 Chan, 1998, Evaluation of a targeted prodrug strategy to enhance oral absorption of poorly water-soluble compounds, Pharm. Res., 15, 1012, 10.1023/A:1011969808907 Ashford, 1993, An in vitro investigation into the suitability of pH-dependent polymers for colon targeting, Int. J. Pharm., 91, 241, 10.1016/0378-5173(93)90344-F Risbud, 2000, pH-sensitive freeze-dried chitosan-polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery, J. Control. Release., 68, 23, 10.1016/S0168-3659(00)00208-X Palmieri, 2000, Polymers with pH-dependent solubility: possibility of use in the formulation of gastroresistant and controlled-release matrix tablets, Drug Dev. Ind. Pharm., 26, 837, 10.1081/DDC-100101307 Gupta, 2001, A novel pH- and timebased multi-unit potential colonic drug delivery system, I. Development. Int. J. Pharm., 213, 83, 10.1016/S0378-5173(00)00649-9 Watts, 1999, Colonic drug delivery, Drug Dev. Ind. Pharm., 23, 893, 10.3109/03639049709148695 Yang, 2004, A novel pH-dependent gradient-release delivery system for nitrendipine I. Manufacturing, evaluation in vitro and bioavailability in healthy dogs, J. Control. Release., 98, 219 Cui, 2003, Design of sustained-release nitrendipine microspheres having solid dispersion structure by quasi-emulsion solvent diffusion method, J. Control. Release, 91, 375, 10.1016/S0168-3659(03)00275-X Yang, 2004, A novel pH-dependent gradient-release delivery system for nitrendipine II, Investigations of the factors affecting the release behaviors of the system. Int. J. Pharm., 286, 99 Kawashima, 1989, Spherical crystallization as a novel particle design technique for oral drug delivery system, Chin. Pharm. J., 41, 163 Gasser, 1999, Lercanidipine, a new third generation Ca-antagonist in the treatment of hypertension, J. Clin. Basic Cardiol., 2, 169 Rawat, 2007, Influence of Selected Formulation Variables on the Preparation of Enzyme-entrapped Eudragit S100 Microspheres, AAPS Pharm Sci Tech, 8, 116, 10.1208/pt0804116 Gao, 2006, Preparation of roxithromycin-polymeric microspheres by the emulsion solvent diffusion method for taste masking, Int. J. Pharm., 318, 62, 10.1016/j.ijpharm.2006.03.018 2005 Alvarez-Lueje, 2003, A selective HPLC method for determination of lercanidipine in tablets, J. Pharm. Biomed. Analysis, 31, 1, 10.1016/S0731-7085(02)00601-5 Mukherjee, 2007, Preparation and characterization of poly-ε-caprolactone particles for controlled insulin delivery, J. Biomed. Pharm. Engg., 1, 40 Pardhakar, 2002, Spherical crystallization of celecoxib, Drug Dev. Ind. Pharm., 28, 1213, 10.1081/DDC-120015354 Li, 2002, In vitro evaluation of dissolution behavior for a colon specific drug delivery system (CODES) in multi-pH media using United States pharmacopeia apparatus II and III, AAPS Pharm Sci Tech, 3, 33, 10.1208/pt030433 Peppas, 1985, Analysis of Fickian and non-Fickian drug release from polymers, Pharm. Acta Helv., 60, 110 Korsmeyer, 1983, Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air, J. Pharm. Sci., 72, 1189, 10.1002/jps.2600721021 Deasy, 1997, Use of extrusion spheronisation to develop an improved oral dosage form of indomethacin, Int. J. Pharm., 148, 201, 10.1016/S0378-5173(96)04846-6